Generation Investment Management LLP is dedicated to long-term investing, integrated sustainability research and client alignment. It is an independent, private, owner-managed partnership established in 2004, with offices in London and San Francisco. Generation Investment Management LLP is authorized and regulated in the United Kingdom by the Financial Conduct Authority.
Idinvest Partners is a leading pan-European private equity firm focused on the mid-market segment with €8 billion under management and has developed several complementary areas of expertise including venture and growth capital investments in innovative European start-ups.
Balderton Capital is one of the largest venture capital firms in Europe, focused on investing in the best European technology companies. Based in London, the firm manages $2.3bn. Since 2000, Balderton has invested in over 100 companies, principally across Europe.
Alychlo is the investment firm of Marc Coucke, a Belgian entrepreneur and the founder of Omega Pharma. Together with an experienced investment team, Marc invests with Alychlo in growing, innovative companies in order to support their further development. Alychlo invests in a range of sectors, but mostly healthcare and with a particular focus on oncology.
360 Capital Partners is a Venture Capital firm, investing in innovation at full scale in Europe. With over €300M under management, 360 Capital Partners is managed by a consolidated team which has cumulated 60+ years of Venture Capital experience investing in, following-up and exiting from over 90 companies.
Invoke Capital is a very different type of technology investor. Founded by some of Europe’s most successful technology entrepreneurs it invests in, and supports, world-leading fundamental technology businesses emerging across Europe.
Swisscom Ventures is the corporate venturing arm of Swisscom AG, the leading Telecommunications provider in Switzerland. As a strategic investor, Swisscom Ventures invests in IT, telecommunication infrastructure and Internet related technologies both in Europe and the USA.
Endeavour Vision combines a team of experienced venture capital professionals who have collectively invested in over 60 companies in 10 countries in both the Life Sciences and Information/Communication Technology. The firm invests in innovative companies which have the potential to become global leaders.